Cargando…
A Pan-Cancer Immunogenomic Atlas for Immune Checkpoint Blockade Immunotherapy
The ability to identify robust genomic signatures that predict response to immune checkpoint blockade is restricted by limited sample sizes and ungeneralizable performance across cohorts. To address these challenges, we established Cancer-Immu (http://bioinfo.vanderbilt.edu/database/Cancer-Immu/), a...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Association for Cancer Research
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189237/ https://www.ncbi.nlm.nih.gov/pubmed/34903605 http://dx.doi.org/10.1158/0008-5472.CAN-21-2335 |